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264 C.-Y. Yeh et al.patients with/without malignant transformation were recorded, and the relation between oral
habits and percentage of initial lymphocyte markers was evaluated using the Student t test and
Fisher’s exact test.
Results: Ten precancer patients developed oral squamous cell carcinoma with a mean period
of malignant transformation of 6.8  2.1 years. Patients with malignant transformation had a
mean age of 48.4  5.0 years (nZ 10), relatively more than that of patients without malignant
transformation (41.6  6.3 years, nZ 18) (p < 0.05). An increase was noted in the population
of peripheral blood mononuclear cells expressing CD4þCD69þ, CD19þCD69þ, and
CD56þCD69þ (p < 0.05) in precancer patients with malignant transformation. Alcohol con-
sumption showed an association with the malignant transformation of patients with precancer
(p Z 0.030), whereas betel quid and smoking showed little effect.
Conclusion: These results suggest that age, alcohol consumption, and early activation of T
cells, B cells, and natural killer cells are crucial in the malignant transformation of oral precan-
cer. Analysis of patient’s lymphocyte populations may help predict the malignant transforma-
tion of oral precancer.
Copyright ª 2015, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
In recent decades, oral cancer has become an important
health problem, and it is one of the top four causes of
cancer death of male in Taiwan.1 Many studies have
revealed a strong correlation between oral cancer inci-
dence and some oral habits. In Taiwan, people with alcohol
drinking, betel quid (BQ) chewing, and smoking habits have
a higher risk of oral precancers, such as oral leukoplakia,
oral erythroplakia, oral submucous fibrosis (OSF), and even
oral squamous cell carcinoma (OSCC).2,3 Various factors
such as ethnic groups, stages of diagnosis, gender, diag-
nostic age, anatomic site, morphologic type, BQ chewing,
and treatment methods have been shown to affect the
prognosis of OSCC.4,5 Consumption of alcohol, BQ chewing,
and cigarette smoking are highly associated with the initi-
ation, promotion, and progression of oral cancer.6e8 How-
ever, whether these oral habits may affect the malignant
transformation of oral precancer is an intriguing issue
awaiting further investigation. Clinically, various thera-
peutic modalities such as radical surgical excision, chemo-
therapy, and radiotherapy, separately or in combination,
have been used for the treatment of OSCC. However, the
overall survival rate for oral cancer patients was 61%,9 and
the survival rates were 75%, 65.6%, 49%, and 30%, respec-
tively, for patients with stage I, II, III, and IV oral cancer.10
Understanding the factors responsible for the malignant
transformation of oral precancer is, therefore, important
for early diagnosis and treatment of OSCC, to improve the
prognosis.
Chemical carcinogens in alcohol, BQ, and cigarette
have been shown to affect the normal structures of pro-
tein, lipid, and DNA of oral mucosal cells, leading to gene
mutation, chromosomal aberrations, and even clinical
cancer.6,7 Most of the damaged DNA can be repaired, and
the transformed cells can be destroyed by the immune
system. However, some transformed cells may escape the
host immune surveillance, resulting in cancer develop-
ment. Accordingly, recent advances in tumor immunology
reveal that an imbalance between effector cells andregulatory cells in different kinds of tumor microenviron-
ments may affect oral cancer initiation, promotion, pro-
gression, and treatment outcomes.11,12 Immunological
changes occur in different stages of oral carcinogenesis.
Presence of cytogenetic damage in lymphocytes isolated
from precancerous patients and impairment of cellular
immune responses in cancer patients have been re-
ported.12,13 Alterations of lymphocyte population and
functional defects in lymphocyte were noted in patients
with different stages of oral cancer.14e16 Analysis of
lymphocyte phenotypes in peripheral blood mononuclear
cells (PBMCs) of patients with oral precancer and cancer,
therefore, can be used potentially to predict disease
progression and treatment outcomes. However, limited
information is known about the changes in phenotypes of
PBMCs in oral precancer patients and their relation to
malignant transformation.
The purposes of this study were to investigate whether
the populations of CD4þ T-helper cells, CD8þ T cells,
CD19þ B cells, and CD56þ natural killer (NK) cells, and
their activation markers (CD25þ and CD69þ) in the initial
diagnostic stage of oral precancer may have an effect on
future malignant transformation. Furthermore, we clarified
the relationship between age or oral habits and the ma-
lignant transformation of oral precancers.
Materials and methods
By the approval of Ethics Committee, National Taiwan
University Hospital, 28 consecutive male patients with oral
precancerous lesion were recruited from the Department of
Oral and Maxillofacial Surgery, National Taiwan University
Hospital, from 1999 to 2004.17 Patients with autoimmune
diseases, those who were taking immunoactive drugs, and
those with evident viral/bacterial infection within 1 month
were excluded from this study. The analytic cohort con-
sisted of 28 male patients with precancerous lesions, with a
mean age of 44.0  6.2 years. Basic information, and clin-
ical and histopathological data of these patients were
recorded during that period (Table 1). Expression of
Table 1 Demographics of the cohort of precancer patients with/without malignant transformation.
Without transformation With transformation Total p
Male n Z 18 n Z 10 n Z 28
Agea 41.6  6.3 48.4  5.0 44.0  6.2 0.02*
Malignant transformation (n Z 10)
<3 y 1
<5 y 5
<10 y 8
<15 y 10
Initial precancer diagnosis (n Z 18) (n Z 10) (n Z 28) 0.128b
Leukoplakia 9 8 17
OSF 8 1 9
Lichen planus 1 0 1
Erythroplakia 0 1 1
Histological finding (n Z 18) (n Z 10) (n Z 28) 0.352b
Hyperplasia 1 1 2
Hyperkeratosis 6 1 7
Mild dysplasia 1 0 1
Moderate or severe dysplasia 6 7 13
Lichen Planus 1 0 1
No report 3 1 4
Malignant transformation (n Z 10)
Tongue Ca. 3
Buccal Ca. 6
Gingival Ca. 1
*Statistically significant difference (p < 0.05).
Ca. Z cancer; OSF Z oral submucous fibrosis.
a Age of initial diagnosis (analyzed by Student t test).
b Chi-square test was used for statistical analysis.
Factors on malignant transformation of oral precancer 265lymphocyte markers in these patients were determined by
flow cytometry, as published previously.17 All patients were
followed for their precancerous lesions with/without ma-
lignant transformation till December 31, 2014.
Isolation of peripheral blood mononuclear cells
In brief, peripheral blood samples (2 mL) were collected
from patients with precancerous lesions prior to incisional
or excisional biopsy. These blood samples were stored at
4C, and the lymphocyte populations were examined within
24e48 hours.
Flow cytometric analysis of lymphocyte
populations
Identification of lymphocyte phenotypes was performed
directly on blood samples collected in anticoagulated EDTA
tubes. Various specific monoclonal antibodies, including
CD4-phycoerythrin(PE)/CD3-fluorescein-isothiocyanate
(FITC), CD8-PE/CD3-FITC, CD19-PE, CD56-PE, CD4-PE/
CD25-FITC, CD8-PE/CD25-FITC, CD19-PE/CD25-FITC, CD56-
PE/CD25-FITC, CD4-PE/CD69-FITC, CD8-PE/CD69-FITC,
CD19-PE/CD69-FITC, and CD56-PE/CD69-FITC, were used to
label cell surface markers. Briefly, 50 mL of whole blood was
taken from each patient, and then 10 mL of antibodies was
added to these tubes. The tubes were vortexed and then
incubated at room temperature for 30 minutes in the dark.
Then, 750 mL of 1 FACS lysis solution was added to eachtube, vortexed gently, and incubated in the dark for 30
minutes. After centrifugation, the cell pellets were resus-
pended in phosphate-buffered saline with 0.5% bovine
serum albumin and analyzed by flow cytometry. The per-
centage of lymphocyte expressing various CD markers was
estimated for analysis.15,17
Statistical analysis
Data were calculated using Microsoft Excel 2003 and pre-
sented as the mean  standard error (SE). Differences in all
categories were analyzed for statistical significance using
the Student t test, chi-square test, and Fisher’s exact test.
A value of p < 0.05 was considered to have statistically
significant difference between groups.Results
The 28 precancer lesions were diagnosed as leukoplakia (17
cases), OSF (9 cases), lichen planus (1 case), and eryth-
roplakia (1 cases). Histopathological observation revealed
the presence of hyperplasia (2 cases), hyperkeratosis (7
cases), mild dysplasia (1 case), moderate to severe
dysplasia (13 cases), and lichen planus (1 case). Four cases
lacked a biopsy report (Table 1). Two OSF cases received no
treatment, and three cases (1 lichen planus, 1 OSF, and 1
leukoplakia) received incisional biopsy only. Excisional bi-
opsy alone was performed in seven cases, whereas in 14
Table 2 Differences in age and CD markers (mean  SE) in precancer patients with/without malignant transformation.
Precancer without malignant transformation Precancer with malignant transformation p (t test)
(n Z 18), mean  SE (n Z 10), mean  SE
Agea 41.6  6.3 48.4  5.0 0.02*
CD4þb 38.0  5.5 42.5  4.6 0.06#
CD8þb 24.5  5.0 23.5  4.3 0.36
CD19þb 14.8  3.6 15.1  3.9 0.44
CD56þb 14.7  8.1 15.9  7.8 0.39
CD4þ/CD8þb 1.7  0.5 1.9  0.5 0.20
CD4þ plus CD8þb 62.4  6.8 66.0  5.9 0.17
CD4 þ CD25þb 6.5  2.1c 7.0  1.7 0.32
CD8 þ CD25þb 2.2  1.8c 1.1  0.6 0.11
CD19 þ CD25þb 0.6  0.6c 0.6  0.3 0.49
CD56 þ CD25þb 0.3  0.3c 0.5  0.3 0.09#
CD4 þ CD69þb 0.4  0.2 0.7  0.2 <0.01*
CD8 þ CD69þb 2.2  1.5 1.9  0.7 0.35
CD19 þ CD69þb 0.1  0.1 0.3  0.2 0.01*
CD56/CD69þb 0.5  0.3 1.1  0.7 0.01*
Student t test was used for statistical analysis.
# A p value of <0.1 was considered borderline significant.
* A p value of <0.05 was statistically significant.
SE Z standard error.
a Age of initial diagnosis.
b Percentage of cells expressing CD markers.
c Data collected (n Z 15).
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sional biopsy and in three cases, a large surgical section was
created, possibly due to histological findings of dysplasia.
Ten precancer patients developed OSCC in the follow-up
period (Table 1). The mean period of malignant trans-
formation was 6.8  2.1 years from the date of initial diag-
nosis. Themean age of precancer patients withoutmalignant
transformation (nZ 18) was 41.6 6.3 years compared with
48.4  5.0 years in precancer patients with malignant
transformation (nZ 10) (p < 0.05). Chi-square test showed
no marked effect of clinical diagnosis (p Z 0.128) and his-
topathological diagnosis (p Z 0.352) on the malignant
transformation of oral precancer (p > 0.05) (Table 1).
The PBMCs expressing CD4þCD69þ, CD19þCD69þ, and
CD56þCD69þ populations showed a statistically significant
difference between the precancer patients with and
without malignant transformation (Table 2). Moreover, a
tendency of changes in CD4þ, CD8þCD25þ, andTable 3 Difference in oral habits (mean  SE) in precancer pa
Precancer without Malignant transformatio
(n Z 18), mean  SE
Alcohol (þ) 11
() 7
Betel (þ) 15
() 3
Smoking (þ) 17
() 1
Analyzed by Fisher exact test.
* A value of p < 0.05 was considered statistically significant.
SE Z standard error.CD56þCD25þ (but p value as 0.06, 0.11, and 0.09,
respectively) of PBMC populations in precancer patients
with and without malignant transformation was also noted.
We analyzed whether oral habits may affect the malig-
nant transformation of oral precancer and found an asso-
ciation between alcohol consumption and the malignant
transformation of patients with precancer (p Z 0.030).
However, BQ chewing and smoking habits showed little
effects, because most of the precancer patients have BQ
chewing and smoking habits (Table 3).Discussion
In this cohort study, we followed 28 oral precancer patients
for more than 10 years. The malignant transformation to
OSCC was found in 35.7% of oral precancer patients, with an
average of 6.8 years from initial diagnosis to OSCC. Our 9-tients with/without malignant transformation.
n Precancer with Malignant transformation p
(n Z 10), mean  SE
10 0.030*
0
10 0.532
0
10 >0.99
0
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rate of 2.6% for oral lichen planus patients. Similarly,
Warnakulasuriya et al18 and Wang et al19 also reported that
the severity of epithelial dysplasia is a critical factor of
malignant transformation of precancer. For this reason,
excisional biopsy or wide surgical removal of diseased tissue
was performed in cases with dysplasia.
Since the 5-year survival rate of OSCC is 61%,9 prediction
and early diagnosis of the malignant transformation of oral
precancer to OSCC is a critical health issue in Taiwan. In this
study, age was found to be a contributing factor for malig-
nant transformation. A recent study also reported that after
surgical excision of oral cancer, elder patients showed a poor
prognosis compared to younger patients.20 This is possibly
due to alterations of lymphocyte and immune response
during aging, accumulation of genotoxic damage, or aber-
rant DNA repair andDNAmethylation in elder patients, which
are important for the pathogenesis of oral cancer.6,12,21,22
Previous studies have found that BQ chewing, smoking,
and alcohol consumption have correlation with the inci-
dence of OSF, oral leukoplakia, and other verrucous lesions.
BQ chewing and smoking show a synergistic effect on these
lesions.23 In vitro cell culture models and in vivo animal
models also reveal the tumor-promoting and inflammatory
effects of BQ components.7,8,24 However, using statistical
models, oral habits including BQ chewing and cigarette
smoking were suggested to be the factors responsible for the
malignant changes of OSCC.25 Using the three-state Markov
model, BQ chewing habit increases the risk of oral leuko-
plakia, but not that of malignant transformation. Smoking
plays a role in leukoplakia, but only aminor role in malignant
transformation, whereas alcohol is crucial for malignancy
but not for leukoplakia.26 In our longitudinal study, we fol-
lowed oral precancer patients for 10 years and found that
alcohol consumption can be an important factor of malig-
nant transformation to OSCC. Since all precancer patients
have BQ chewing and smoking habits, no conclusion can be
made regarding the effects of both habits on malignant
transformation. The tumor-promoting effect of alcohol can
be due to its local or systemic effects, such as disturbance of
systemic metabolism of nutrient, and alteration of redox
metabolism and signaling pathways.27 Alcohol may also
enhance the permeability of oral mucosa, act as a solvent of
tobacco carcinogen, induce basal cell proliferation, and
generate free radicals and acetaldehyde that have the
abilities to induce DNA damage, malnutrition, and immune
suppression, to promote carcinogenesis.28
A number of studies have suggested that immune
response plays critical roles in the pathogenesis of oral
precancer and oral cancer. Evaluation of lymphocyte
phenotypes in peripheral blood can help in knowing the
systemic immune status of patients.12,29 It is generally
known that CD4þ T-helper cells, CD8þ T cells, and CD56þ
NK cells may inhibit and kill tumor cells to impede tumor
growth,30 whereas B cells are important to control immune
response and as an inflammatory regulator.31 In this study,
no marked difference in CD4þ, CD8þ, CD4þ plus CD8þ,
CD19þ, and CD56þ cell populations and in CD4þ/CD8 ratio
was noted in precancer patients with and without malig-
nant transformation. This suggests that these populations
of T cells, T-helper cells, NK cells, and B cells are not
involved in the malignant transformation of oralprecancer. While cancer cells have been shown to induce
the apoptosis of T cells and NK cells,32 this event can be a
late cancer stage response.
In addition, CD8þCD25þ (p Z 0.11), CD4þCD25þ,
CD19þCD25þ, and CD56þCD25þ (p Z 0.09) populations
showed no statistically significant difference in precancer
patients with and without malignant transformation. Not
all T cells are antitumor effector immune cells.
CD4þCD25þFoxp3þ, termed regulatory T cells, may sup-
port tumor growth and progression, and inhibit immune
response against cancer.30 An increase in CD25þ regula-
tory T cells in the blood has been found in pancreatic and
breast cancer patients relative to normal donors.30 The
results of this study suggest that CD25þ lymphocyte pop-
ulation may be not directly involved in the malignant
transformation of oral precancer. However, more studies
with an increased sample size are necessary to further
confirm the results.
Interestingly, we found that CD4þCD69þ, CD19þCD69þ,
and CD56þCD69þ populations, but not CD8þCD69þ popu-
lation, showed a significant difference in precancer patients
with and without malignant transformation. An elevation of
CD4þCD69þFoxp3e regulatory T cells in hapatocellular
carcinoma patients was reported, and these cells may
suppress T-cell response via membrane-bound transforming
growth factor-b and may be involved in tumor progression.33
CD69 is an early activation marker of lymphocytes.34 In-
creases in early activation of CD4þCD69þ T cells,
CD19þCD69þ B cells, and CD56þCD69þ NK cells in pre-
cancer patients with malignant transformation suggest that
CD69þ expression in T, B, and NK cells might be important
for the malignant transformation of oral precancer. These
alterations in lymphocyte phenotypes may be due to the
toxic effects of BQ, tobacco, alcohol, or other toxicants.
In conclusion, the etiology of oral cancer is multifacto-
rial, including genetic, environmental, social, and behav-
ioral factors. Age, alcohol drinking, and cellular immune
response, in terms of their effects on the malignant trans-
formation of oral precancer to OSCC, showed some differ-
ences between precancer patients with or without
malignant transformation. Expression of CD4þCD69þ,
CD19þCD69þ, and CD56þCD69þ lymphocyte populations
plays important roles in this event, highlighting the
importance of cellular immunity in the pathogenesis of
OSCC. In addition, to stop usage of BQ, tobacco, and
alcohol, an analysis of lymphocyte markers of peripheral
blood in precancer patients may be useful for the predic-
tion and early diagnosis of malignant changes to OSCC.Acknowledgments
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